ArticleSeminars in arthritis and rheumatism2025

Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial.

Samantha Kohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.